Robert Mackie named chief risk officer at Mellon HBV
Mellon HBV Alternative Strategies has hired Robert A. Mackie as chief risk officer as the firm continues to grow and maximize its investment offerings.
Mellon HBV Alternative Strategies has also promoted James P. Jenkins to portfolio manager of its long-only distressed investments.
Mackie joins Mellon HBV as the firm continues to grow and expand its investment offerings. Jenkins' new role has been created to maximize the potential in the distressed area and to foster continued growth in this successful strategy at the firm.
Jonathan S. Bean, Mellon HBV managing director, said: "These organizational changes come as a result of continued growth at the firm, and improving opportunities in the distressed arena. We believe Bob's expertise, and Jim's new role in the distressed group will further streamline the investment process while providing Mellon HBV management with enhanced risk controls."
Mackie, 42, in the newly created position of chief risk officer is responsible for managing the firm's overall investment risk including monitoring fund positions and assessing overall market exposure. Mackie was most recently managing director at Allen & Company Inc. Prior to that he was a trader at Herzog, Heine & Geduld, Inc.
Jenkins, 56, has been promoted to portfolio manager for all long-only distressed investments. Jenkins joined Mellon HBV in 2002 as managing director and portfolio manager, charged with creating and managing a dedicated long-only control oriented distressed strategy. In his expanded role, he will orchestrate all long-only investments in the firm's three distressed strategies. Prior to joining Mellon HBV, Jenkins spent many years as an investment banker, including at Lehman Brothers and Credit Suisse First Boston, where in the early 1990s he helped form the first Distressed Securities Group.
George J. Konomos, 65, remains as portfolio manager for the firm's hedged distressed strategy. Konomos' distressed investing expertise stretches three decades, including managing a private equity fund at Baker, Nye Investments, and serving as a senior advisor to the World Bank.
Messrs. Mackie, Jenkins and Konomos report to William F. "Mickey" Harley, chief investment officer. Harley also serves as senior portfolio manager of the eight-member Distressed Investment Group, which manages more than USD 550 million in client assets (as of July 31).
Background Note: Mellon HBV Alternative Strategies LLC is an investment management company that seeks superior risk-adjusted investment performance primarily for institutional investors via an array of alternative investment disciplines. Headquartered in New York with a wholly owned investment management subsidiary located in London. Mellon HBV has combined assets under management in excess of USD1.2 billion in four primary investment disciplines: Arbitrage (U.S. Risk Arbitrage, Global Risk Arbitrage, Convertible Arbitrage), Distressed (Hedged Distressed, Long-Biased Trading Oriented Distressed, Long-Only Control Oriented Distressed, Long-OnlTrading Oriented Distressed); Event Driven (U.S. Event Driven, European Event Driven), and Multi-Strategy Investing. Mellon HBV Alternative Strategies is a US Securities and Exchange Commission registered investment advisor, and its subsidiary, Mellon HBV Alternative Strategies U.K. Limited, is regulated by the Financial Services Authority in the United Kingdom.
- By Category
- News from other sites
- Special Reports
- Partner events